Prostatis Group’s Fidelity Blue Chip Growth ETF FBCG Stock Holding History

Prostatis Group’s Portfolio FBCG Stock Details FBCG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$652K	Buy	10,492 +1,051	+11%	+$62.4K	0.15%	99
2026 Q1	$473K	Buy	9,441 +2,094	+29%	+$111K	0.12%	107
2025 Q4	$403K	Buy	7,347 +1,700	+30%	+$92.2K	0.1%	115
2025 Q3	$303K	Buy	+5,647	New	+$288K	0.08%	128

Other funds holding FBCG

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DWM

Dynasty Wealth Management St. Petersburg, Florida $13.5B AUM 21.55% 1-Year Est. Return

SWP

Sagespring Wealth Partners Franklin, Tennessee $6.51B AUM 25.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Prostatis Group's FBCG Position: Q2 2026 in Review

Prostatis Group increased its Fidelity Blue Chip Growth ETF (FBCG) stake by 11% in Q2 2026, buying an estimated $62.4K and bringing the position to 10,492 shares worth $652K. The position accounts for 0.15% of the portfolio, ranked #99.

Prostatis Group first reported a position in FBCG in Q3 2025 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold FBCG as of Q2 2026.

Prostatis Group held 10,492 shares of Fidelity Blue Chip Growth ETF worth $652K as of Q2 2026.
Prostatis Group bought 1,051 Fidelity Blue Chip Growth ETF shares in Q2 2026, an estimated $62.4K.
Fidelity Blue Chip Growth ETF made up 0.15% of Prostatis Group's portfolio in Q2 2026, its #99 holding.
Prostatis Group first reported a position in Fidelity Blue Chip Growth ETF in Q3 2025 and has held it in 4 quarters since.
317 funds tracked by Wall St. Rank held Fidelity Blue Chip Growth ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.